tiprankstipranks
Kissei Pharmaceutical Co Ltd (JP:4547)
:4547
Japanese Market

Kissei Pharmaceutical Co (4547) Financial Statements

Compare
0 Followers

Kissei Pharmaceutical Co Financial Overview

Kissei Pharmaceutical Co's market cap is currently ¥191.98B. The company's EPS TTM is ¥; its P/E ratio is 14.92; and it has a dividend yield of 2.48%. Kissei Pharmaceutical Co is scheduled to report earnings on ―, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 88.33B¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B
Gross Profit¥ 44.06B¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B
Operating Income¥ 5.77B¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B
EBITDA¥ 20.25B¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B
Net Income¥ 11.96B¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B
Balance Sheet
Cash & Short-Term Investments¥ 48.65B¥ 45.93B¥ 49.60B¥ 53.15B¥ 44.45B
Total Assets¥ 244.06B¥ 260.93B¥ 221.20B¥ 238.09B¥ 268.86B
Total Debt¥ 1.60B¥ 1.73B¥ 1.95B¥ 1.98B¥ 2.18B
Net Debt¥ -23.57B¥ -21.17B¥ -23.94B¥ -28.03B¥ -18.28B
Total Liabilities¥ 33.93B¥ 39.79B¥ 26.38B¥ 35.91B¥ 48.90B
Stockholders' Equity¥ 209.00B¥ 220.03B¥ 193.90B¥ 201.39B¥ 219.31B
Cash Flow
Free Cash Flow¥ 2.01B¥ -2.88B¥ -8.78B¥ 44.00M¥ -3.47B
Operating Cash Flow¥ 6.52B¥ -1.68B¥ -6.68B¥ 1.53B¥ -2.54B
Investing Cash Flow¥ 4.95B¥ 8.69B¥ 6.00B¥ 10.78B¥ -9.33B
Financing Cash Flow¥ -9.32B¥ -10.01B¥ -3.42B¥ -2.76B¥ -4.00B
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History

Kissei Pharmaceutical Co Debt to Assets

Kissei Pharmaceutical Co Cash Flow

Kissei Pharmaceutical Co Forecast EPS vs Actual EPS